Clinical Trials Browser

OTHER × Stomach Neoplasms × atezolizumab × Clear all

NCT04157985 2025-12-11

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Phase 3 Completed

DermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma

NCT03421288 2025-07-25

DANTE

Phase 2 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT04166721 2025-04-06

WaKING: Wnt and checKpoint INhibition in Gastric Cancer

Phase 1/2 Active not recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT04739202 2021-03-29

IMMUNOGAST

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms